Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

The Lancet Child and Adolescent Health

Volumn 2, Issue 5, 2018, Pages 338-349

  Claeys, Carine ^a,g   Zaman, Khalequ ^b,g   Dbaibo, Ghassan ^c,g   Li, Ping ^d,g   Izu, Allen ^d,g   Kosalaraksa, Pope ^e,g   Rivera, Luis ^f,g   Acosta, Beatriz ^g   Arroba Basanta, Maria Luisa ^g,h   Aziz, Asma ^b,g   Cabanero, Miguel Angel ^g,i   Chandrashekaran, Vijayalakshmi ^d,g   Corsaro, Bartholomew ^d,g   Cousin, Luis ^g,j   Diaz, Adolfo ^g,k   Diez Domingo, Javier ^g,l   Dinleyici, Ener Cagri ^g,m   Faust, Saul N ^g,n,o   Friel, Damien ^a   Garcia Sicilia, Jose ^g,p   Gomez Go, Grace D ^g,q   Antoinette Gonzales, Maria Liza ^r   Hughes, Stephen M ^g,s   Jackowska, Teresa ^g,t   Kant, Shashi ^g,u   Lucero, Marilla ^g,v   Malvaux, Ludovic ^a,g   Mares Bermudez, Josep ^g,w   Martinon Torres, Federico ^g,x   Miranda, Mariano ^y   Montellano, May ^g,q   Peix Sambola, Maria Amor ^g,z   Prymula, Roman ^g,aa   Puthanakit, Thanyawee ^g,ab   Ruzkova, Renata ^g,ac   Sadowska Krawczenko, Iwona ^g,ad,ae   Salamanca de la Cueva, Ignacio ^g,af   Sokal, Etienne ^ag   Soni, Jyoti ^g,ah   Szymanski, Henryk ^ai   Ulied, Angels ^g,aj   Schuind, Anne ^d,g   Jain, Varsha K ^d,g   Innis, Bruce L ^d,g   Acostas, Beatriz ^g   Amanullah, Arshad ^g   Ariza, Miguel ^g   Bautista, Milagros ^g   Bavdekar, Ashish ^g   Bodalia, Bhavesh ^g   Bravo, Lulu C ^g   Brzostek, Jerzy ^g   Caldwell, Ian ^g   Carmona, Alfonso ^g   Danier, Jasur ^g   Diaz Cirujano, Ana Isabel ^g   Docx, Martine ^g   Drazan, Daniel ^g   Galaj, Andrzej ^g   Garcia Rodriguez, Fermin ^g   Gonzales, Maria Liza Antoinette ^g   Gooding, Trevor ^g   Hacimustafaoglu, Mustafa ^g   Heaton, Paul ^g   Lalwani, Sanjay ^g   Langlands, Jennifer ^g   Logghe, Karl ^g   Mantyka, Jolanta ^g   McNally, Damien ^g   Miszczak Kowalska, Edyta ^g   Royal, Simon ^g   Sablan, Benjamin ^g   Snape, Matthew ^g   Tomlinson, Richard ^g   Verghote, Marc ^g   Vertruyen, Andre ^g   Wheeler, Marie ^g   more..

^a GSK   (Belgium)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d GLAXOSMITHKLINE   (United States)

^e KHON KAEN UNIVERSITY   (Thailand)

^f Universidad Autónoma de Santo Domingo   (Dominican Republic)

^g Complutense University of Madrid ^*

^h UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

ⁱ UNIVERSITAT JAUME I   (Spain)

^j Tecnologia en Investigacion   (Honduras)

^k NATIONAL AUTONOMOUS UNIVERSITY OF HONDURAS   (Honduras)

^l Centre of Public Health Research   (Spain)

^m ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

ⁿ UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^o UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^p HOSPITAL INFANTIL LA PAZ   (Spain)

^q Mary Chiles Hospital   (Philippines)

^r UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^s ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^t MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^u ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^v RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^w Institut Pediatric Mares Riera   (Spain)

^x Instituto de Salud Carlos III   (Spain)

^y Hospital Antequera   (Spain)

^z BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^aa UNIVERSITY OF HRADEC KRALOVE   (Czech Republic)

^ab CHULALONGKORN UNIVERSITY   (Thailand)

^ac Medicentrum 6 sro   (Czech Republic)

^ad NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^ae University Hospital No 2   (Poland)

^af Instituto Hispalense de Pediatria   (Spain)

^ag CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^ah GlaxoSmithKline Pharmaceuticals Ltd   (India)

^ai St Hedwig of Silesia Hospital   (Poland)

^aj EBA Centelles   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

APNEA; ARTICLE; ASIA; BACTERIUM ISOLATE; CENTRAL AMERICA; CHILD; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EUROPE; FACIAL NERVE PARALYSIS; FEBRILE CONVULSION; FEMALE; HUMAN; HYPERSENSITIVITY; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; MALE; NEPHROTIC SYNDROME; PHASE 3 CLINICAL TRIAL; POPULATION RESEARCH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SEROCONVERSION; THROMBOCYTOPENIC PURPURA; VACCINATION; VIRUS ISOLATION; VIRUS STRAIN; CLINICAL TRIAL; CONTROLLED STUDY; INFANT; INFLUENZA; INTERNATIONAL COOPERATION; MULTICENTER STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SEASON; SINGLE BLIND PROCEDURE;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERNATIONALITY; MALE; SEASONS; SINGLE-BLIND METHOD;

EID: 85045202685     PISSN: None     EISSN: 23524642     Source Type: Journal    
DOI: 10.1016/S2352-4642(18)30062-2     Document Type: Article

References (33)

1. Neuzil, KM, Zhu, Y, Griffin, MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 185 (2002), 147–152.
2. Neuzil, KM, Mellen, BG, Wright, PF, Mitchel, EF Jr, Griffin, MR, The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 (2000), 225–231.
3. Zhou, H, Thompson, WW, Viboud, CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis 54 (2012), 1427–1436.
4. Loeb, M, Russell, ML, Moss, L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 303 (2010), 943–950.
5. King, JC Jr, Stoddard, JJ, Gaglani, MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 355 (2006), 2523–2532.
6. Pebody, RG, Warburton, F, Ellis, J, et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill, 20, 2015, 21025.
7. Brownstein, JS, Kleinman, KP, Mandl, KD, Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am J Epidemiol 162 (2005), 686–693.
8. Sage Working Group. Background paper on influenza vaccines and immunization. http://www.who.int/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf (accessed Sept 11, 2017).
9. Jefferson, T, Rivetti, A, Di Pietrantonj, C, Demicheli, V, Ferroni, E, Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev, 8, 2012 Cd004879.
10. Hoberman, A, Greenberg, DP, Paradise, JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 290 (2003), 1608–1616.
11. Jansen, AG, Sanders, EA, Hoes, AW, van Loon, AM, Hak, E, Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial. J Pediatr 153 (2008), 764–770.
12. Vesikari, T, Knuf, M, Wutzler, P, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 365 (2011), 1406–1416.
13. Hurwitz, ES, Haber, M, Chang, A, et al. Studies of the 1996–1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis 182 (2000), 1218–1221.
14. Rolfes, MA, Goswami, D, Sharmeen, AT, et al. Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh. Vaccine 35 (2017), 6967–6976.
15. Maeda, T, Shintani, Y, Nakano, K, Terashima, K, Yamada, Y, Failure of inactivated influenza A vaccine to protect healthy children aged 6–24 months. Pediatr Int 46 (2004), 122–125.
16. WHO. FluNet—charts. http://www.who.int/influenza/gisrs_laboratory/flunet/charts/en/ (accessed Sept 11, 2017).
17. European Centre for Disease Control and Prevention. Seasonal influenza 2011–2012 in Europe (EU/EEA countries). https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/120312-TER-Seasonal-influenza-risk-assessment.pdf (accessed Sept 11, 2017).
18. van Baalen, CA, Jeeninga, RE, Penders, GHWM, et al. ViroSpot microneutralization assay for antigenic characterization of human influenza viruses. Vaccine 35 (2017), 46–52.
19. Hehme, N, Künzel, W, Petschke, F, et al. Ten years of experience with the trivalent split-influenza vaccine, Fluarix. Clin Drug Invest 22 (2002), 751–769.
20. Jain, VK, Rivera, L, Zaman, K, et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med 369 (2013), 2481–2491.
21. Saunders, NR, Tennis, O, Jacobson, S, Gans, M, Dick, PT, Parents' responses to symptoms of respiratory tract infection in their children. CMAJ 168 (2003), 25–30.
22. Dos Santos, G, Neumeier, E, Bekkat-Berkani, R, Influenza: can we cope better with the unpredictable?. Hum Vaccin Immunother 12 (2016), 699–708.
23. Centers for Disease Control and Prevention. Seasonal influenza vaccine effectiveness. http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm, 2005–2016 (accessed Sept 11, 2017).
24. Neuzil, KM, Hohlbein, C, Zhu, Y, Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med 156 (2002), 986–991.
25. Chung, A, Perera, R, Brueggemann, AB, et al. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ, 335, 2007, 429.
26. Samore, MH, Magill, MK, Alder, SC, et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 108 (2001), 856–865.
27. Langley, JM, Carmona Martinez, A, Chatterjee, A, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis 208 (2013), 544–553.
28. Wang, L, Chandrasekaran, V, Domachowske, JB, Li, P, Innis, BL, Jain, VK, Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in US children 6–35 months of age during 2013–2014: results from a phase II randomized trial. J Pediatric Infect Dis Soc 5 (2016), 170–179.
29. Langley, JM WL, Aggarwal, N, Bueso, A, et al. Immunogenicity and reactogenicity of an inactivated quadrivalent influenza vaccine administered intramuscularly to children 6 to 35 months of age in 2012–2013: a randomized, double-blind, controlled, multicenter, multicountry, clinical trial. J Pediatric Infect Dis Soc 4 (2015), 242–251.
30. Jain, V, Domachowske, J, Wang, L, et al. Time to change dosing of inactivated quadrivalent influenza vaccine in young children: evidence from a phase III, randomized, controlled trial. J Pediatric Infect Dis Soc 6 (2017), 9–19.
31. Greenberg, DP, Robertson, CA, Landolfi, VA, Bhaumik, A, Senders, SD, Decker, MD, Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age. Pediatr Infect Dis J 33 (2014), 630–636.
32. WHO. Influenza (seasonal). Fact sheet. http://www.who.int/mediacentre/factsheets/fs211/en/ (accessed Jan 19, 2018).
33. Madhi, SA, Klugman, KP, The Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nature Med 10 (2004), 811–813.